| 1 |
31689244 | Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models. | 2020 Feb 3 |
2 |
| 2 |
30864227 | Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux. | 2019 Oct |
1 |
| 3 |
29191929 | Correction: Inhibition of mTORC1 Kinase Activates Smads 1 and 5 but Not Smad8 in Human Prostate Cancer Cells, Mediating Cytostatic Response to Rapamycin. | 2018 Jan |
1 |
| 4 |
22452883 | Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin. | 2012 Jun |
3 |
| 5 |
19642865 | Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. | 2010 Apr |
1 |